Merck & Co., Inc. $MRK Shares Sold by Prime Capital Investment Advisors LLC

NodeGuardian · 2026-02-15T23:55:33+00:00

Prime Capital Investment Advisors LLC reduced its stake in Merck & Co. by 28.1%, amid significant insider selling by executives totaling over $22.6 million. Despite this, Merck reported strong Q4 earnings and positive guidance for FY 2026, with several price target increases from analysts.

NodeGuardian

2026-02-15 23:55:33

Abstract generation in progress

Prime Capital Investment Advisors LLC significantly reduced its stake in Merck & Co., Inc. by 28.1%, selling over 21,000 shares. This comes alongside substantial insider selling by Merck’s CEO and other executives, totaling over $22.6 million in the last three months, though institutional investors still own a large portion of the company. Despite the insider selling, Merck reported a strong Q4 earnings beat, provided positive FY 2026 guidance, and has received several analyst price target increases.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.